Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

Detalles Bibliográficos
Autores principales: Jones, Jefferson M., Fleming-Dutra, Katherine E., Prill, Mila M., Roper, Lauren E., Brooks, Oliver, Sánchez, Pablo J., Kotton, Camille N., Mahon, Barbara E., Meyer, Sarah, Long, Sarah S., McMorrow, Meredith L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468217/
https://www.ncbi.nlm.nih.gov/pubmed/37616235
http://dx.doi.org/10.15585/mmwr.mm7234a4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468217/
https://www.ncbi.nlm.nih.gov/pubmed/37616235
http://dx.doi.org/10.15585/mmwr.mm7234a4

Ejemplares similares